| Kabra Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524322 |
NSE Symbol : - |
P/E(TTM) : 5.47 |
|
ISIN Demat : INE323K01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.20 |
|
Book Value(₹) : 12.49 |
Market Cap(₹Cr) : 41.51 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 46.22 | 35.41 | 30.42 | 19.76 | 7.15 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 46.22 | 35.41 | 30.42 | 19.76 | 7.15 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.08 | 0.11 | 0.18 | 0.18 | 0.02 | 0.64 |
| Total Income | 46.29 | 35.52 | 30.60 | 19.94 | 7.17 | 0.64 |
| Total Expenditure | 43.43 | 34.07 | 27.99 | 17.73 | 7.66 | 0.24 |
| PBIDT | 2.87 | 1.45 | 2.62 | 2.22 | -0.50 | 0.40 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 2.86 | 1.44 | 2.61 | 2.22 | -0.50 | 0.40 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 |
| Tax | 0.72 | 0.36 | 0.03 | 0.37 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 2.12 | 1.06 | 2.57 | 1.84 | -0.50 | 0.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.12 | 1.06 | 2.57 | 1.84 | -0.50 | 0.39 |
| EPS (Unit Curr.) | 0.90 | 0.45 | 1.08 | 0.77 | -0.21 | 0.21 |
| EPS (Adj) (Unit Curr.) | 0.90 | 0.45 | 1.08 | 0.77 | -0.21 | 0.21 |
| Calculated EPS (Unit Curr.) | 0.90 | 0.45 | 1.08 | 0.77 | -0.21 | 0.17 |
| Calculated EPS (Adj) (Unit Curr.) | 0.90 | 0.45 | 1.08 | 0.77 | -0.21 | 0.17 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.58 | 1.79 | 4.33 | 3.10 | -0.84 | 0.66 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.58 | 1.79 | 4.33 | 3.10 | -0.84 | 0.66 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.71 | 23.71 | 23.71 | 23.71 | 23.71 | 23.71 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.21 | 4.09 | 8.61 | 11.23 | -6.99 | 0.00 |
| PBDTM(%) | 6.19 | 4.07 | 8.58 | 11.23 | -6.99 | 0.00 |
| PATM(%) | 4.59 | 2.99 | 8.45 | 9.31 | -6.99 | 0.00 |
